Eupraxia Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.58

+0.20 (+2.39%)

As of Sep 20, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +416.8% upside

Low Target $25.23

Average Target $44.34

High Target $48.95

Current Price $8.58

Current
$8.58

Target
$44.34

$25.23 $44.34 avg $48.95

Scenario Analysis

Bear Case

$25.23

194.1%

Low target

Base Case

$44.34

+416.8%

Avg target

Bull Case

$48.95

+470.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$12.86

-33.3% from high

52-Week Low

$7.35

+16.7% from low

Target vs 52W High

$44.34

+244.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%